Azad David 4
4 · ACURA PHARMACEUTICALS, INC · Filed Aug 1, 2011
Insider Transaction Report
Form 4
Azad David
Director
Transactions
- Award
Director Stock Options
2011-07-28+6,250→ 6,250 totalExercise: $3.03Exp: 2021-07-27→ Common Stock (6,250 underlying)
Footnotes (2)
- [F1]Fifty percent (50%) of shares underlying options vest on, and are exercisable commencing, each of September 30, 2011 and December 31, 2011.
- [F2]Not Applicable.